Final answer:
Growth hormone (GH) is regulated by GHRH and GHIH and affects growth and protein synthesis. IGF-1, an insulin-like growth factor, is involved in the indirect action of GH for tissue growth. For deficient patients, recombinant human growth hormone treatments can be administered.
Step-by-step explanation:
The student has asked about the product that stimulates natural production and release of growth hormone (GH). GH is a hormone produced by the anterior pituitary gland that primarily promotes protein synthesis and body growth. It acts both directly and through an indirect mechanism involving insulin-like growth factors (IGFs), particularly IGF-1, which is known to activate osteocytes and promote bone cell production and tissue growth.
GH levels in the body are regulated by hormonal stimuli involving the hypothalamus. Specifically, growth hormone-releasing hormone (GHRH) triggers the release of GH, while growth hormone-inhibiting hormone (GHIH), also known as somatostatin, inhibits GH production.
For individuals whose pituitary glands do not produce sufficient GH, recombinant human growth hormone (HGH) treatments are available. These medical interventions are essential for patients with specific deficiencies and are part of a controlled therapeutic process.